- Inflammation, Microenvironment, and the Immune System in Cancer Progression
[作者:Keibel, A; Singh, V; Sharma, MC,期刊:Current Pharmaceutical Design, 页码:1949-1955 , 文章类型: Review,,卷期:2009年15-17]
- Since Virchow first proposed in 1863 that tumors could originate from sites of chronic inflammation, it has been well established that chronic inflammation both contributes to cancer progression and predisposes tissue to...
- Regenerative Medicine: Does Erythropoietin have a Role?
[作者:Buemi, M; Lacquaniti, A; Maricchiolo, G; Bolignano, D; Campo, S; Cernaro, V; Sturiale, A; Grasso, G; Buemi, A; Allegra, A; Donato, V; Genovese, L,期刊:Current Pharmaceutical Design, 页码:2026-2036 , 文章类型: Review,,卷期:2009年15-17]
- Regenerative Medicine, a recent new medical domain, aims to develop new therapies through the stimulation of natural regenerative processes also in human beings. In this field, Erythropoietin (EPO) represents a significa...
- The Impact of Diabetes Mellitus on Coronary Artery Disease: New Therapeutic Approaches
[作者:Tousoulis, D; Kampoli, AM; Papageorgiou, N; Papaoikonomou, S; Antoniades, C; Stefanadis, C,期刊:Current Pharmaceutical Design, 页码:2037-2048 , 文章类型: Review,,卷期:2009年15-17]
- Patients with diabetes mellitus (DM) type 2 have a high prevalence of coronary artery disease ( CAD), as diabetes is implicated in the formation of atherosclerotic plaque. Hyperglycemia, elevated free fatty acid, increas...
|